Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoelzer

Showing results (311-320 of 415) with videos related to

Pageof 42
Sort By:
Haematology and Blood Transfusion|January 1, 1987
Morphological and cytochemical classification of adult acute leukemias in two multicenter studies in the Federal Republic of GermanyH Löffler, W Kayser, N Schmitz, et al.
Blood|January 1, 1988
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adultsD Hoelzer, E Thiel, H Löffler, et al.
Seminars in Oncology|June 1, 1987
Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemiaD Hoelzer, E Thiel, H Löffler, et al.
Blood|June 15, 1992
In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cellsM Eder, O G Ottmann, T E Hansen-Hagge, et al.
British Journal of Haematology|February 13, 2001
T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chainsS Boehrer, T Hinz, D Schui, et al.
Annals of Hematology|May 6, 2004
Risk/MRD adapted GMALL trials in adult ALLN Gökbuget, R Raff, M Brügge-Mann, et al.
Deutsche Medizinische Wochenschrift (1946)|December 4, 2004
[The competence network "acute and chronic leukemias"]R Hehlmann, U Berger, C Aul, et al.
Der Internist|March 9, 2004
[Clinical research in the "acute and chronic leukemias"competence network ]R Hehlmann, U Berger, C Aul, et al.
Onkologie|August 1, 1983
[Recruiting patients and results of a preliminary study on the therapy of acute lymphatic leukemia and acute undifferentiated leukemia in adults]D Hoelzer, E Thiel, H Löffler, et al.
Onkologie|February 1, 1988
[Intensive combined therapy for high-risk ALL patients]D Hoelzer, E Thiel, H Löffler, et al.
Pageof 42

Showing results (311-320 of 415) with videos related to

Sort By:
Pageof 42
Haematology and Blood Transfusion|January 1, 1987
Morphological and cytochemical classification of adult acute leukemias in two multicenter studies in the Federal Republic of GermanyH Löffler, W Kayser, N Schmitz, et al.
Blood|January 1, 1988
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adultsD Hoelzer, E Thiel, H Löffler, et al.
Seminars in Oncology|June 1, 1987
Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemiaD Hoelzer, E Thiel, H Löffler, et al.
Blood|June 15, 1992
In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cellsM Eder, O G Ottmann, T E Hansen-Hagge, et al.
British Journal of Haematology|February 13, 2001
T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chainsS Boehrer, T Hinz, D Schui, et al.
Annals of Hematology|May 6, 2004
Risk/MRD adapted GMALL trials in adult ALLN Gökbuget, R Raff, M Brügge-Mann, et al.
Deutsche Medizinische Wochenschrift (1946)|December 4, 2004
[The competence network "acute and chronic leukemias"]R Hehlmann, U Berger, C Aul, et al.
Der Internist|March 9, 2004
[Clinical research in the "acute and chronic leukemias"competence network ]R Hehlmann, U Berger, C Aul, et al.
Onkologie|August 1, 1983
[Recruiting patients and results of a preliminary study on the therapy of acute lymphatic leukemia and acute undifferentiated leukemia in adults]D Hoelzer, E Thiel, H Löffler, et al.
Onkologie|February 1, 1988
[Intensive combined therapy for high-risk ALL patients]D Hoelzer, E Thiel, H Löffler, et al.
Pageof 42